Views & Analysis Live Well: when health and opportunity knocks Live Well brings health products to the doorsteps of rural Zambians in an innovative partnership between GSK and CARE International.
Market Access Biosimilar switches and healthcare gains Despite being used across Europe for more than a decade, biosimilar medications are still something of a mystery among those outside the sector.
Market Access Matt Hancock has big shoes to fill as he takes over from Jer... What changes will the appointment of Matt Hancock MP as Secretary of State for Health and Social Care mean for the NHS?
Views & Analysis Who should pay for HTA? Part of the drive for strengthening EU cooperation on health technology assessment (HTA) is to tackle duplication of work
Views & Analysis Patient centricity makes ethical and commercial sense Patient centricity is no longer a buzzword, it’s an essential way of conducting business that makes both ethical and commercial sense.
Views & Analysis Will plausibility reign supreme in Lyrica second medical use... Pharma needs clarity from the Supreme Court on whether the whole scope of a patent claim must be plausible at the time of the application.
News Activist investor renews its criticism of Novavax Shah Capital has fired another broadside at vaccine firm Novavax, accusing its board and management of a "destruction in shareholder value."
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.